Arthritis Pain Relief
Progressus Revenue offers an innovative clinical business model focused on resolving osteoarthritic knee pain currently suffered by over 27 million Americans.
Osteoarthritis Relief Program
This program is a non-surgical approach to the treatment of knee pain caused by osteoarthritis and provides equipment, training, patient marketing, billing, and support services to turn your practice into a multi-million-dollar earner. Our complete turnkey solution is covered by Medicare and most commercial plans with proper documentation and preauthorization per plan requirements.
The Opportunity
Covered by most insurance companies
Prolongs the need for surgery
Minimal injection sessions (5)
Recommended by Medicare
FDA approved since 1996
Studies show consistent and significant reduction in pain and prolonged need for surgery
Hyaluronic Acid is FDA approved and recommended by Medicare. Guided injections can prolong the need for surgery and provide a significant and consistent reduction in pain.
Complete Program And System Provided
Designed for the clinician that already has an established practice but does not yet offer Osteoarthritis treatment options as a component of their business model. Once an equipment package is purchased, we provide the necessary marketing, training, supplies and even practitioner staffing, DME and credentialing services, if needed.
PORTABLE MINI C-ARM & X-RAY COMBO PACKAGE
Fluoroscopic guidance offers the ability to perform arthrogram diagnostic
procedures for increased accuracy of injection placement and added
case profitability, as well as digital x-ray in a fully portable platform.
EQUIPMENT DESCRIPTION
Mini C-Arm – Multi-use portable fluoroscopy and x-ray including applicable
accessories, training, and installation with a one-year parts and labor
warranty.
Medical Grade Procedure Table/Chair provides added comfort and safety
for the patient and ease of access for the provider performing exam or
injections.;
Projected Income And Profits: Average Bilateral Case Example
OA Program consists of fluoroscopic guided injections of Hyaluronic Acid and unloading knee brace. An estimated breakdown of the typical bilateral course of care is outlined below. Reimbursement figures are based upon the national average fee schedule.
Your first case each month covers the fixed costs of the program. Ongoing management of schedule, workflow, and billing provided by Progressus will help guarantee consistency.
Potential NET Revenue per Case – $3,900* blended average on federal and commercial payers. Potential Monthly NET Revenue at 20 cases per month – $78,000 NET*, 20 cases represent a minimal expectation.
| Initial Examination and X-Ray | $200 |
| Initial Arthrogram with Report | $550 |
| Unloading Knee Brace | $1,600 |
| Suspension Sleeve* | $150 |
| Fluoroscopic Guided HA Injections | $2,400 |
| Total Average Gross Reimbursement | $4,900 |
| Total Average Net Reimbursement^ | $3,900 |
*addition to knee brace
^less cost of goods
